Legal aspects of contraceptive implants

Journal of Family Planning and Reproductive Health Care

Volumn 36, Issue 4, 2010, Pages 243-248

  Rowlands, Sam ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; ETONOGESTREL; LEVONORGESTREL; NEXPLANON; UNCLASSIFIED DRUG;

BLOOD VESSEL INJURY; BURNING SENSATION; CARPAL TUNNEL SYNDROME; CLINICAL PRACTICE; DEVICE REMOVAL; HAND PARESTHESIA; HUMAN; HYPESTHESIA; MEDIAN NERVE; MEDICOLEGAL ASPECT; MUSCLE ATROPHY; NERVE INJURY; NEURALGIA; NOTE; PARESTHESIA; PATIENT SAFETY; SENSORY DYSFUNCTION; ULNAR NERVE; ULNAR NERVE PARALYSIS;

EID: 78149318418     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118910793048485     Document Type: Note

References (55)

1. Vincent C. Patient Safety. Edinburgh, UK: Churchill Livingstone, 2006.
2. Merry AF. How does the law recognize and deal with medical errors? J R Soc Med 2009; 102: 265-271.
3. Bismark M, Paterson R. No-fault compensation in New Zealand: harmonizing injury compensation, provider accountability, and patient safety. Health Aff 2006; 25: 278-283. (Pubitemid 43202452)
4. Waters A. GPs advised to stop inserting Norplant. GP 1995; 29 September 1995.
5. Rowlands S. Protecting new contraceptive methods. Contraceptive Education Bulletin 1997; Winter 1997: 5.
6. Robins J. Norplant case collapses as tobacco multi-party action trips up in court. Law Society Gazette 1999; 10 February 1999.
7. Boonstra H, Duran V, Gamble VN, Blumenthal P, Dominguez L, Pies C. The 'boom and bust' phenomenon: the hopes, dreams, and broken promises of the contraceptive revolution. Contraception 2000; 61: 9-25.
8. Entwistle VA, Watt IS, Johnson F. The case of Norplant as an example of media coverage over the life of a new health technology. Lancet 2000; 355: 1633-1636.
9. Committee on Contraceptive Research and Development. Contraceptive Research, Introduction, and Use: Lessons from Norplant. Washington, DC: Institute of Medicine, 1998.
10. Association of Reproductive Health Professionals. Health Matters Fact Sheet. The Single Rod Contraceptive Implant. 2008. http://www.arhp.org/ Publications-and-Resources/Patient-Resources/fact-sheets/single-rod [Accessed 22 July 2010].
11. Mansour D. Nexplanon®: what Implanon® did next. J Fam Plann Reprod Health Care 2010; 36: 187-189.
12. Mansour D, Mommers E, Teede H, Sollie-Eriksen B, Graesslin O, Ahrendt H-J, et al. Clinician satisfaction and insertion characteristics of a new applicator to insert radiopaque Implanon: an open-label, noncontrolled, multicenter trial. Contraception 2010; 82: 243-249.
13. Mascarenhas L. Insertion and removal of Implanon®. Contraception 1998; 58(Suppl. 6): 79S-83S.
14. Croxatto HB, Mäkäräinen L. The pharmacodynamics and efficacy of Implanon. Contraception 1998; 58: 91S-97S.
15. Rowlands S, Sujan MA, Cooke M. Risk management aspects of contraceptive implants. J Fam Plann Reprod Health Care 2010; 36: 191-195.
16. Bensouda-Grimaldi L, Jonville-Bera AP, Beau-Salinas F, Llabres S, Autret-Leca E. Insertion problems, removal problems and contraception failures with Implanon® [in French]. Gynecol Obstet Fertil 2005; 33: 986-990.
17. Stillwell S, Sheppard P, Searle S. The impalpable Implanon®: a case report. J Fam Plann Reprod Health Care 2003; 29: 156-157.
18. Singh M, Mansour D, Richardson D. Location and removal of non-palpable Implanon® implants with the aid of ultrasound guidance. J Fam Plann Reprod Health Care 2006; 32: 153-156.
19. Medicines and Healthcare products Regulatory Agency (MHRA). The Yellow Card Scheme - Collecting Information on Adverse Drug Reactions. http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Medicines/ index.htm#1 [Accessed 17 July 2010].
20. Court imposes the burden of proof on the women in case of Implanon unintended pregnancies [in Dutch]. The Legal Daily, 28 August 2007. http://juridischdagblad.nl/content/view/5549/53/ [Accessed 17 July 2009].
21. McFarlane v Tayside Health Board [2000] 2 AC 59, MLC 0127, HL. 2000.
22. Wood M, Price S. Lawsuits flying over 'failed' contraceptive. Sydney Morning Herald, 13 February 2005.
23. Dunson TR, Amatya RN, Kreuger SL. Complications and risk factors associated with the removal of Norplant implants. Obstet Gynecol 1995; 85: 543-547.
24. Walling M. How to remove impalpable Implanon® implants. J Fam Plann Reprod Health Care 2005; 31: 320-321.
25. Mansour D, Fraser IS, Walling M, Glenn D, Graesslin O, Egarter C, et al. Methods of accurate localisation of non-palpable subdermal contraceptive implants. J Fam Plann Reprod Health Care 2008; 34: 9-12.
26. Navani M, Robinson C. Clinical challenge with Implanon® removal: a case report. J Fam Plann Reprod Health Care 2005; 31: 161-162. (Pubitemid 40604573)
27. Ismail H, Mansour D, Singh M. Migration of Implanon®. J Fam Plann Reprod Health Care 2006; 32: 157-159.
28. Cozens NJA. Contraceptive implants: high resolution ultrasonography facilitates removal. Br Med J 1996; 313: 880.
29. Evans R, Holman R, Lindsay E. Migration of Implanon®: two case reports. J Fam Plann Reprod Health Care 2005; 31: 71-72. (Pubitemid 40127837)
30. Westerway SC, Picker R, Christie J. Implanon implant detection with ultrasound and magnetic resonance imaging. Aust N Z J Obstet Gynaecol 2003; 43: 346-350. (Pubitemid 37304225)
31. Shulman LP, Gabriel H. Management and localization strategies for the nonpalpable Implanon rod. Contraception 2006; 73: 325-330.
32. Sarma SP, Silverstein M, Lewis C. Removal of a Norplant® implant located near a major nerve using interventional radiology-digital subtraction fluoroscopy. Contraception 1998; 58: 387-389.
33. Newton MP, Mascarenhas L, Xiao-Feng L, Newton J. Experience with contraceptive implants: removal technique, classification of difficulties and the importance of correct placement. Br J Fam Planning 1995; 21(Suppl.): 14-16.
34. Nelson AL, Sinow RM. Real-time ultrasonographically guided removal of nonpalpable and intramuscular Norplant capsules. Am J Obstet Gynecol 1998; 178: 1185-1193.
35. Mansour D. UK provision for removal of non-palpable contraceptive implants. J Fam Plann Reprod Health Care 2009; 35: 3-4.
36. Faculty of Sexual & Reproductive Healthcare. For a woman using the etonogestrel implant, Implanon, which has been found to be located in her biceps muscle, should it be removed under local anaesthetic? Members' Enquiry 1766. 20 September 2006. Clinical Effectiveness Unit: on file.
37. James P, Trenery J. Ultrasound localisation and removal of non-palpable Implanon implants. Aust N Z J Obstet Gynaecol 2006; 46: 225-228. (Pubitemid 44056730)
38. Vidin E, Garbin O, Rodriguez B, Favre R, Bettahar-Lebugle K. Removal of etonogestrel contraceptive implants in the operating theater: report on 28 cases. Contraception 2007; 76: 35-39. (Pubitemid 46935117)
39. C v Sefton Primary Care Trust Lawtel LTLPI; 24 August 2005.
40. Mansour D, Walling M, Glenn D, Egarter C, Graesslin O, Herbst J, et al. Removal of non-palpable etonogestrel implants. J Fam Plann Reprod Health Care 2008; 34: 89-91.
41. Mourtialon P, Tixier H, Loffroy R, Maillart JC, Calmelet P, Dellinger P, et al. Vascular complication after insertion of a subcutaneous contraceptive implant. Acta Obstet Gynecol Scand 2008; 87: 1256-1258.
42. Searle ES. Norplant neuropathy [Letter]. Br J Fam Planning 1994; 20: 101.
43. Chang A, Edlich RF, Himel HN. Local reactions at the insertion site of the Norplant contraceptive system. J Long Term Eff Med Implants 1993; 3: 305-312. (Pubitemid 24032963)
44. Sarma SP, Hatcher RA. Neurovascular injury during removal of levonorgestrel implants. Am J Obstet Gynecol 1995; 172: 120-121.
45. Arribas-Mir L, Rueda-Lozano D, Agrela-Cardona M, Cedeno-Benavides T, Olvera-Porcel C, Bueno-Cavanillas A. Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain. Contraception 2009; 80: 457-462.
46. Nash C, Staunton T. Focal brachial cutaneous neuropathy associated with Norplant® use: suggests careful consideration of the recommended site for inserting contraceptive implants. J Fam Plann Reprod Health Care 2001; 27: 155-156.
47. Wechselberger G, Wolfram D, Pülzl P, Soelder E, Schoeller T. Nerve injury caused by removal of an implantable hormonal contraceptive. Am J Obstet Gynecol 2006; 195: 323-326.
48. Webb AMC. Why go to Tiger Country? A report of two cases of Implanon® removal. J Fam Plann Reprod Health Care 2006; 32: 193-194.
49. Marin R, McMillian D. Ulnar neuropathy associated with subdermal contraceptive implant. South Med J 1998; 91: 875-678.
50. Smith JM, Conwit RA, Blumenthal PD. Ulnar nerve injury associated with removal of Norplant implants. Contraception 1998; 57: 99-101.
51. Osman N, Mirlesse V. A new complication of contraceptive hormonal implant: about two cases of lesions of the ulnar nerve at the arm level [in French]. Gynecol Obstet Fertil 2005; 33: 322-325. (Pubitemid 40798604)
52. Bragg TWH, Jose RM, Bland JW, Matthews RN, Srivastava S. Implantable contraceptive devices: primum non nocere. J Fam Plann Reprod Health Care 2006; 32: 190-192. (Pubitemid 44105877)
53. Anonymous. Nerve damage blamed on contraceptive implant placement. Clinician Reviews 2007; 17: 15.
54. Medicines and Healthcare products Regulatory Agency (MHRA). Download Drug Analysis Prints (DAPs). http://www.mhra.gov.uk/Onlineservices/Medicines/ Druganalysisprints/index.htm [Accessed 22 July 2010].
55. Berner LS. Implants, Norplant: dejà vu all over again. J Womens Health 1995; 4: 353-355.